Agent Capital
Agent Capital is a healthcare venture capital firm focused on novel technologies and therapeutics that address unmet patient need.
📥 Buy Full VC Dataset
Offices: Waltham (United States), Cambridge (United States)
Investment Stages: Seed, Series A, Series B, Series C
Markets: Rare Diseases, Oncology, Neurology, Immunology
Founded Year: 2017
Investor Type: Venture Capital
Portfolio Companies: Affini-T, AshiBio, Carbon Biosciences, Carisma Therapeutics, Cerevance, Cyrus Biotechnology, Dice Therapeutics, Dragonfly Therapeutics, Entrada Therapeutics, Flare Therapeutics, Foresight Diagnostics, Freenome, Hinge Bio, ImCheck Therapeutics, Immunitas Therapeutics, Interius BioTherapeutics, Mediar Therapeutics, Metagenomi, Orbital Therapeutics, Orbus Therapeutics, Orchard Therapeutics, Palvella Therapeutics, Pliant Therapeutics, Precision Biosciences, Primrose Bio, Pyxis Oncology, Q32 Bio, Skyhawk Therapeutics, Star Therapeutics, TRex Bio, Verge Genomics, ViTToria Biotherapeutics, Zenas Biopharma
Website: https://www.agentcapital.com
Portfolio Link: https://www.agentcapital.com/portfolio
LinkedIn: https://www.linkedin.com/company/agentcapital/
Crunchbase: https://www.crunchbase.com/organization/agent-capital
Comments
No comments yet. Be the first to comment!